Phase I trial to determine the safety and pharmacokinetics of an immediate instillation of apaziquone in the bladder following transurethral resection of bladder tumor (TURBT) in patients with bladder cancer in Japan

Trial Profile

Phase I trial to determine the safety and pharmacokinetics of an immediate instillation of apaziquone in the bladder following transurethral resection of bladder tumor (TURBT) in patients with bladder cancer in Japan

Completed
Phase of Trial: Phase I

Latest Information Update: 26 May 2016

At a glance

  • Drugs Apaziquone (Primary)
  • Indications Bladder cancer
  • Focus Adverse reactions
  • Sponsors Nippon Kayaku
  • Most Recent Events

    • 07 Jan 2011 This trial has been initiated according to a Spectrum Pharmaceuticals media release.
    • 07 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top